N‐Terminal Pro‐B‐Type Natriuretic Peptide as a Biomarker for the Severity and Outcomes With COVID‐19 in a Nationwide Hospitalized Cohort

BACKGROUND: Currently, there is limited research on the prognostic value of NT‐proBNP (N‐terminal pro‐B‐type natriuretic peptide) as a biomarker in COVID‐19. We proposed the a priori hypothesis that an elevated NT‐proBNP concentration at admission is associated with increased in‐hospital mortality....

Descripción completa

Detalles Bibliográficos
Autores principales: O’Donnell, Christian, Ashland, Melanie D., Vasti, Elena C., Lu, Ying, Chang, Andrew Y., Wang, Paul, Daniels, Lori B., de Lemos, James A., Morrow, David A., Rodriguez, Fatima, O’Brien, Connor G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9075235/
https://www.ncbi.nlm.nih.gov/pubmed/34889112
http://dx.doi.org/10.1161/JAHA.121.022913

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9075235/
https://www.ncbi.nlm.nih.gov/pubmed/34889112
http://dx.doi.org/10.1161/JAHA.121.022913

Ejemplares similares